Inari Medical Stock (NASDAQ:NARI), Analyst Ratings, Price Targets, Predictions

The latest price target for Inari Medical (NASDAQ: NARI) was reported by Canaccord Genuity on May 1, 2024. The analyst firm set a price target for $55.00 expecting NARI to rise to within 12 months (a possible 32.82% upside). 19 analyst firms have reported ratings in the last year.

The latest analyst rating for Inari Medical (NASDAQ: NARI) was provided by Canaccord Genuity, and Inari Medical maintained their buy rating.

There is no last upgrade for Inari Medical.

The last downgrade for Inari Medical Inc happened on February 29, 2024 when Piper Sandler changed their price target from $85 to $55 for Inari Medical Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Inari Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Inari Medical was filed on May 1, 2024 so you should expect the next rating to be made available sometime around May 1, 2025.

While ratings are subjective and will change, the latest Inari Medical (NARI) rating was a maintained with a price target of $75.00 to $55.00. The current price Inari Medical (NARI) is trading at is $41.41, which is out of the analyst’s predicted range.